CLINICAL SCIENCES CORE (CORE C)The Clinical Sciences Core (CSC; Core C) will be the focal point of all D-CFAR clinical andtranslational research activities. A major goal for the Core will be to provide expertise and services tofacilitate the design, implementation and conduct of HIV/AIDS clinical trials by D-CFAR investigators.The Core will be directed by Dr. Michael Keefer, who has extensive administrative and clinical researchexperience. The Core will provide support for clinical and translational research by developing a'Protocol Team Service' that draws on the 20 year experience of the major UR HIV/AIDS clinicalresearch programs. While fiscal restraints obviously limit the extent to which a 'network-like' supportstructure can be established, our extensive expertise will allow us to proceed in a step-wise fashion toprovide an 'investigator-centered' service that addresses the most pressing needs that clinicalresearchers face as they design, implement and conduct their studies. The 'Protocol Team Service'will also leverage other expertise within the D-CFAR and the UR institution as a whole to present acoordinated menu of services that the program's D-CFAR investigators can access. Intellectualassistance will be provided through a 'protocol design' service, and laboratory assays provided incollaboration with the Virology/Immunology Core (Core D). A second area of focus for Core C will bethe creation of a 'Biostatistical Service' designed to meet investigator needs that were identified duringthe strategic planning process for this D-CFAR application (including the needs of international partnersin South Africa; see below). The third area of emphasis will be on 'Specialized Services' - notablybiomathematical modeling (which is a major institutional strength at UR) and clinical pharmacologyservices. Finally, the activities and services of Core C will be designed to build upon the growingcollaboration that the UR is nurturing with successful research colleagues in South Africa. Dr. Keefer'scurrent close working relationship with Dr. Glenda Gray (U-Witwatersrand [UWj / Perinatal HIVResearch Centre [PHRU]) and Dr. Linda-Gail Bekker (U-Cape Town [UCT] / Desmond Tutu HIV Centre[DTHC]) through HVTN operations will form the initial foundation of the collaboration. It is our goal forthe UR-South African collaboration to evolve into a broad-based inter-institutional collaboration in yearsto come.
Showing the most recent 10 out of 192 publications
